CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Treatment with Sofosbuvir and Daclatasvir (with or without Ribavirin) Improves Patient Reported Outcomes in Hepatitis C
Lucas Pereira Jorge de Medeiros, Mario Barreto Correa Lima, Marcia Maria Amêndola Pires, Alessandra Mendonça Almeida Maciel, Renata Barboza Vianna Medeiros, Mariana Dermínio Donadel, Isabela Martins Becattini Pereira, Fábio Marchon Leão, Luiz Eduardo Amorim Correa Lima Pires, Helio Rzetelna, Carlos Eduardo Brandão-Mello
Osong Public Health Res Perspect. 2018;9(2):50-58.   Published online April 30, 2018

Excel Download

Daclatasvir + sofosbuvir dominates sofosbuvir + ribavirin
PharmacoEconomics & Outcomes News. 2017;784(1):12-12   Crossref logo
Link1 Link2 Link3

Treatment with Sofosbuvir and Daclatasvir (with or without Ribavirin) Improves Patient Reported Outcomes in Hepatitis C
Osong Public Health and Research Perspectives. 2018;9(2):50-58   Crossref logo
Link1 Link2 Link3

P1-092: The efficacy of sofosbuvir/velpatasvir/ribavirin in cirrhotic, genotype 3a HCV patients, previously failures to sofosbuvir/daclatasvir/ribavirin combination
Journal of Viral Hepatitis. 2018;25:71-71   Crossref logo
Link1 Link2

P7: Daclatasvir + sofosbuvir with or without ribavirin in patients with chronic HCV infection: interim analysis of a multicenter compassionate use program
Journal of Viral Hepatitis. 2014;21:24-25   Crossref logo
Link1 Link2 Link3

751 Patient-Reported Outcomes in Chronic Hepatitis C Patients With Cirrhosis Treated With Ribavirin-Containing Regimens: Sofosbuvir/Velpatasvir and Ribavirin or Sofosbuvir and Ribavirin
Gastroenterology. 2016;150(4):S1046   Crossref logo
Link1 Link2

Reactions Weekly. 2019;1780(1):124-124   Crossref logo
Link1 Link2 Link3

P1-105: Real life data about sofosbuvir, daclatasvir and ribavirin in the treatment of cirrhotic and non cirrhotic HCV patients
Journal of Viral Hepatitis. 2018;25:77-78   Crossref logo
Link1 Link2

Daclatasvir–sofosbuvir combination therapy with or without ribavirin for hepatitis C virus infection: from the clinical trials to real life
Hepatic Medicine: Evidence and Research. 2016;21   Crossref logo

New incidence or recurrence hepatocellular carcinoma (HCC) in genotype 4 hepatitis C virus treated with sofosbuvir/daclatasvir with or without ribavirin
F1000Research. 2021;10:1105   Crossref logo
Link1 Link2 Link3

High success rates for the use of sofosbuvir/ombitasvir/paritaprevir/ritonavir + ribavirin and sofosbuvir/simeprevir/daclatasvir + ribavirin in retreatment of chronic hepatitis C infection after unsuccessful sofosbuvir/daclatasvir therapy: a real-life experience
Archives of Virology. 2020;165(7):1633-1639   Crossref logo
Link1 Link2 Link3